Shares

17 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2023

Nov 09, 2023

BUY
$138.78 - $176.51 $556,507 - $707,805
4,010 Added 1007.54%
4,408 $700,000
Q2 2023

Aug 09, 2023

BUY
$138.42 - $180.31 $55,091 - $71,763
398 New
398 $56,000
Q1 2022

May 12, 2022

SELL
$161.19 - $257.96 $779,676 - $1.25 Million
-4,837 Closed
0 $0
Q4 2021

Feb 11, 2022

BUY
$247.59 - $304.47 $1.2 Million - $1.47 Million
4,837 New
4,837 $1.28 Million
Q2 2021

Aug 10, 2021

SELL
$165.87 - $220.95 $203,024 - $270,442
-1,224 Closed
0 $0
Q1 2021

May 12, 2021

BUY
$180.37 - $226.26 $220,772 - $276,942
1,224 New
1,224 $238,000
Q3 2020

Nov 12, 2020

SELL
$122.51 - $158.27 $141,376 - $182,643
-1,154 Closed
0 $0
Q2 2020

Aug 13, 2020

BUY
$94.33 - $140.48 $108,856 - $162,113
1,154 New
1,154 $143,000
Q1 2020

May 13, 2020

SELL
$84.96 - $109.14 $237,803 - $305,482
-2,799 Closed
0 $0
Q4 2019

Feb 10, 2020

BUY
$73.84 - $93.08 $200,770 - $253,084
2,719 Added 3398.75%
2,799 $259,000
Q3 2019

Nov 12, 2019

BUY
$76.65 - $95.51 $6,132 - $7,640
80 New
80 $6,000
Q2 2019

Aug 09, 2019

SELL
$54.2 - $85.95 $344,766 - $546,727
-6,361 Closed
0 $0
Q1 2019

May 13, 2019

BUY
$49.45 - $62.8 $314,551 - $399,470
6,361 New
6,361 $376,000
Q2 2018

Aug 14, 2018

SELL
$35.26 - $47.04 $430,841 - $574,781
-12,219 Closed
0 $0
Q1 2018

May 11, 2018

BUY
$30.92 - $37.27 $377,811 - $455,402
12,219 New
12,219 $442,000
Q4 2017

Feb 09, 2018

SELL
$32.53 - $38.92 $94,564 - $113,140
-2,907 Closed
0 $0
Q3 2017

Nov 15, 2017

BUY
$36.98 - $46.06 $107,500 - $133,896
2,907
2,907 $111,000

Others Institutions Holding RGEN

About REPLIGEN CORP


  • Ticker RGEN
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Medical Instruments & Supplies
  • Shares Outstandng 55,491,200
  • Market Cap $7.91B
  • Description
  • Repligen Corporation develops and commercializes bioprocessing technologies and systems for use in biological drug manufacturing process in North America, Europe, the Asia Pacific, and internationally. It offers Protein A ligands that are the binding components of Protein A affinity chromatography resins; and cell culture growth factor products....
More about RGEN
Track This Portfolio

Track Group One Trading, L.P. Portfolio

Follow Group One Trading, L.P. and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Group One Trading, L.P., based on Form 13F filings with the SEC.

News

Stay updated on Group One Trading, L.P. with notifications on news.